Document is current
Any future updates will be listed below
-
Authors
Palacka, Katerina
Hermankova, Barbora
Cervena, Tereza
Rossner, Pavel
Holan, Vladimir
Javorkova, Eliska
-
Funding
Funding for this research was provided by:
Grantová Agentura České Republiky (21 17720S, 21 17720S, 21 17720S, 21 17720S, 21 17720S)
Grant Agency of Charles University (122, 122)
Ministerstvo Školství, Mládeže a Tělovýchovy (CZ.02.01.01/00/22_008/0004562, CZ.02.01.01/00/22_008/0004562, CZ.02.01.01/00/22_008/0004562, CZ.02.01.01/00/22_008/0004562, CZ.02.01.01/00/22_008/0004562)
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 17 June 2025
First Online: 1 July 2025
Declarations
:
: The authors declare no competing interests.
: The use of animals was approved in July 2022 by the Local Ethical Committee of the Institute of Experimental Medicine of the Czech Academy of Science, Prague. The title of the approved project is Therapeutic potential of local application of mesenchymal stem cells in combination with silver nanoparticles for the treatment of retinal degenerative disease (approval code 6130/2022).
